This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bayer Innovation Gmbh. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Hans-Herrmann Schulz
Introduction
Hans-Herrmann Schulz is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of medicine, particularly in the use of chemotherapeutic agents. His work focuses on developing treatments for diseases caused by bacteria, which can be crucial for both humans and animals.
Latest Patents
Schulz holds a patent for the "Use of chemotherapeutic agents." This invention relates to the production of a medicament intended for the topical and/or local treatment of bacterial diseases. It also addresses prophylactic measures, showcasing the potential to improve health outcomes in various medical scenarios. He has 1 patent to his name.
Career Highlights
Hans-Herrmann Schulz is associated with Bayer Innovation GmbH, a leading company in the pharmaceutical industry. His role at Bayer allows him to collaborate with other experts and contribute to innovative healthcare solutions. His work is instrumental in advancing the understanding and application of chemotherapeutic agents.
Collaborations
One of his notable coworkers is Günther Schlimbach. Together, they work on projects that aim to enhance the efficacy of treatments and improve patient care.
Conclusion
Hans-Herrmann Schulz's contributions to the field of medicine through his innovative patent demonstrate his commitment to improving health outcomes. His work at Bayer Innovation GmbH continues to influence the development of effective treatments for bacterial diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile